Experimental Alpelisib May Help Treat Some Advanced-Stage BC

Options
Moderators
Moderators Member Posts: 25,912

Experimental Alpelisib May Help Treat Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer With Specific Mutation
November 6, 2018

Experimental alpelisib combined with Faslodex improved progression-free survival more than Faslodex alone in people diagnosed with advanced-stage, hormone-receptor-positive, HER2-negative breast cancer with a PIK3CA mutation. Read more...

Categories